-0.51 | -3.05%
| Price and Volume | |
|---|---|
| Recent Price | 16.73 |
| 52 Week High | 19.90 |
| 52 Week Low | 12.47 |
| Avg. Daily Vol. (Mil) | 1.26 |
| Beta (3 year) | 0.83 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,939.95 |
| Shares Out (Mil) | 235.50 |
| Float (Mil) | 226.32 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.17 |
| Total Debt / Equity | 0.23 |
| Valuation Ratios | |
| Price Earnings | 40.80 |
| Price/Sales | 3.28 |
| Price/Book | 1.50 |
| Price/Cash Flow | 14.60 |
| Per Share Data | |
| Earnings | 0.41 |
| Sales | 5.10 |
| Book Value | 11.15 |
| Cash Flow | 1.15 |
| Business Summary | |
|---|---|
| Qiagen NV is a provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples. Assay technologies are used to make such isolated biomolecules visible for subsequent analysis. | |
| General Information | |
| Spoorstraat 50
Venlo, 5911 KJ |
|
| 1.0 | |
| www.qiagen.com | |
| Industry : Diversified Services | |
| Sector: Services | |
| Employees: 3900 | |
| CEO: Peer M. Schatz | |
| Short Interest | |
| Current Month (Mil) | 9.59 |
| Previous Month (Mil) | 9.04 |
| Short Interest Ratio (Days) | 6.90 |
| Management Effectiveness | |
| Return on Equity | 3.70 |
| Return on Assets | 2.50 |
| Return on Investments | 3.10 |
| Profitability | |
| Gross Margin | 75.90 |
| EBIT Margin | 9.80 |
| Profit Margin | 8.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,430.15 | 1,315.94 | 2,834.33 | 16.31 |
Oil *
103.41
|
|
DOWN
150.54 |
DOWN
16.48 |
DOWN
36.66 |
DOWN
1.00 |
10 Yr
1.63%
SPDR Gold
150.33
|
|
-1.20%
|
-1.24%
|
-1.28%
|
-5.78%
|
Data delayed 20 minutes |
Connect with TheStreet